🔎 Trials Near Me

Početna › Imunološki sustav i poremećaji › New York

Kliničke studije za Imunološki sustav i poremećaji u državi New York

14 studija za Imunološki sustav i poremećaji traži sudionike na lokacijama u državi New York.

Gradovi u državi New York

Službeni tekst studije (engleski)

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

  • Memorial Sloan Kettering Cancer Center, New York
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07192471

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  • Memorial Sloan Kettering Cancer Center, New York
  • Montefiore Medical Center, The Bronx
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 18. ruj 2026. · NCT06722235

Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

  • Hematology Oncology Associates of Central New York-Auburn, Auburn
  • Roswell Park Cancer Institute, Buffalo
  • Hematology Oncology Associates of CNY at Camillus, Camillus
  • i još 5
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Oba spola · Ažurirano 17. ruj 2026. · NCT04242095

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  • Memorial Sloan Kettering Cancer Center, New York
  • Montefiore Medical Center, The Bronx
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 9. ruj 2026. · NCT06948318

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

  • Roswell Park Comprehensive Cancer Center, Buffalo
  • David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
  • Montefiore Medical Center, The Bronx
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 25. kol 2026. · NCT05826535

Abatacept for the Treatment of Giant Cell Arteritis

  • Hospital for Special Surgery, New York
U tijeku regrutacijaFaza 3
Od 50 godina i više · Oba spola · Ažurirano 20. kol 2026. · NCT04474847

Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.

  • NY Nephrology, Clifton Park
  • Icahn School of Medicine at Mount Sinai, New York
U tijeku regrutacijaFaza 3
Od 18 do 100 godina · Oba spola · Ažurirano 17. kol 2026. · NCT06858319

A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

  • Inmagene Site 6, Kew Gardens
  • Inmagene Site 21, New York
  • Inmagene Site 11, Woodbury
U tijeku regrutacijaFaza 2
Od 18 do 74 godina · Oba spola · Ažurirano 12. kol 2026. · NCT07037901

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

  • Weill Cornell Medicine - New York Presbyterian Hospital, New York
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 7. srp 2026. · NCT07216443

A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition

  • Columbia University Irving Medical Center, New York
U tijeku regrutacijaFaza 2
Sve dobne skupine · Oba spola · Ažurirano 2. lip 2026. · NCT05787574

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

  • Roswell Park Comprehensive Cancer Center, Buffalo
  • Mt Sinai, New York
  • Memorial Sloan Kettering Cancer Center, New York
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 16. tra 2026. · NCT03328078

Biologics And Clinical Immunology Cohort at Sinai

  • Mount Sinai, New York
U tijeku regrutacijaOpažajna studija
Od 12 godina i više · Oba spola · Ažurirano 17. velj 2026. · NCT04784364

BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled Asthma

  • Sun River Health, Beacon
  • Bedford Stuyvesant Family Health Center, Brooklyn
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 18 godina i više · Oba spola · Ažurirano 30. sij 2026. · NCT05341726

Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.